Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

SAFE AND WELL Angela McKinnon Feb What is Safe and Well? A document building on previous guidance - part of the SE reform programme Supplement.
Accident Incident Policy Changes to Policy September 2007.
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
Chronic Pain Management Elaine Wendt, MD. Pain is now “Fifth Vital Sign”
Succeeding not seceding: The work of the Texas legislative workgroup on integrated healthcare Mary Lehman Held, L.C.S.W. Lynda E. Frost, J.D., Ph.D. Katherine.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
EFFECTIVE DELEGATION AND SUPERVISION
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
Pain Management: a Regulatory Perspective William J. Schmidt, J.D. Senior Counsel, Investigations, Compliance & Enforcement Randy Beck Investigative Supervisor.
RENI PRIMA GUSTY, SK.p,M.Kes
DEALING WITH GOVERNMENT SCRUTINY OF PAIN MANAGEMENT BY PRIMARY CARE PHYSICIANS How To Anticipate And Avoid Government Interference With This Crucial Area.
Kenneth B Simons, MD Chair, WI MEB Chair, FSMB SMART Workgroup.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Pharmacy and Therapeutics Committee
1 Maine’s New Medicinal Marijuana Law Maine Association of Psychiatric Physicians April 30, 2010 Gordon H. Smith, Esq. Executive Vice President Maine Medical.
Scope of Practice and Licensure
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Risk Management, Assessment and Planning Committee III-4.
Respect and Advocacy Sabato A. Stile M.D.. Worldwide, Complex, Public Health Problem affects people from all demographic and social groups and economic.
# 1: F 282 The services provided or arranged by the facility must be provided by qualified persons in accordance with each resident’s written plan of.
QUALITY IMPROVEMENT AND PATIENT SAFETY. WHAT IS QUALITY ?
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
 the study of the rightness or wrongness of human conduct.  In any situation involving two or more individuals, values may come into conflict and ethical.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 1 Nursing Diagnoses: Issues and Controversies.
Section 504 of the Rehabilitation Act of 1973 Purpose Prohibit discrimination against persons with disabilities in programs receiving federal financial.
Maximising professionalism Module 6. Contents The tasks The roles The collaboration between staff The communication between staff and patients The physical.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Medicated Assisted Treatment (MAT) Terry R. Jones Director of Behavioral Health.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
SOONERCARE PAIN MANAGEMENT PROGRAM. SOONERCARE PAIN MANAGEMENT PROGRAM The SoonerCare Pain Management Program is designed to equip SoonerCare providers.
EFFECTIVE DELEGATION AND SUPERVISION
IOWA BOARD OF MEDICINE MARK BOWDEN, MPA, CMBE EXECUTIVE DIRECTOR IOWA BOARD OF MEDICINE.
WELCOME TO SEMINAR 4. RISKS TO THE MEDICAL OFFICE Fraud: An intentional deception or misrepresentation made by an individual who knows that the false.
Issues in Palliative Sedation Bruce A. Ferrell, MD Professor of Clinical Medicine UCLA David Geffen School of Medicine Director of Palliative Care.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Medication Assisted Treatment
Off-label Use.
Long Term Care Provider
Government Affairs Update
Wireless Access SSID: cwag2017
Legal and Regulatory Issues in Pain Management
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Regulatory Issues and Effective Pain Management
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
© 2010 Jones and Bartlett Publishers, LLC
Medical Practice Acts and State Boards
Bigger. Bolder..
David McBride MD Boston University Department of Family Medicine
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
CHAPTER 4 Information Management in Pharmacy.
From Exam Room to Courtroom
Opioid Prescribing & Monitoring
Complete a legally valid prescription.
MDHHS Response to the Opioid Crisis
Federal Regulations requirements for opioid prescription course
Prescription Drug Monitoring Program
By Alan I. Kaplan, Attorney at Law
Prescription Drug Monitoring Program
National Credentialing Forum 2019 San Diego, CA February
F 514: COMPLETE, ACCURATE, ACCESSIBLE RESIDENT RECORDS
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.

Proper Prescribing Definitions Non-therapeutic prescribing - A medical use or purpose that is not legitimate Prescribing pharmaceuticals or practicing consistent with the public health and welfare - Prescribing pharmaceuticals and practicing medicine for a legitimate medical purpose in the usual course of professional practice.

Intractable pain A pain state in which the cause of the pain cannot be removed or otherwise treated and which in the generally accepted course of medical practice no relief or cure of the cause of the pain is possible or none has been found after reasonable efforts.

Proper Prescribing for Pain Guidelines for the proper prescribing for pain according to Board rule Documented medical history Physical examination Recognized medical indication Written treatment plan Discuss risks and benefits of medication with patient

Proper Prescribing for Pain Guidelines for the proper prescribing for pain according to Board rule (Cont’d) Periodic review at reasonable intervals Complete and accurate records Closer monitoring of patients with history of substance abuse

Prescribing Practices Warranting Board Scrutiny Issuing prescriptions for large amounts of controlled substances and/or in excess of prescribed dosage Failing to keep accurate records Failing to evaluate/monitor patients Prescribing to drug-dependent persons without adequate consultation/evaluation and monitoring

Controlled Substance Violations (Prescribing Violations)

Actions by Percentage of Totals

Challenge to State Medical Boards To protect the medical uses of controlled substances and simultaneously prevent drug diversion and abuse Ensure public access to effective pain control

Status of State Pain Policies/Laws

Pain Management and State Regulatory Policy A project funded by the Robert Wood Johnson Foundation Purpose –Develop model guidelines for use by state medical boards and other healthcare regulatory agencies to promote the appropriate prescribing of controlled substances (opioids) in the management of chronic malignant and non-malignant pain

Project Objectives Establish consistent standards for managing chronic pain based on current research data Promote a non-legislative approach to address the use of controlled substances in the management of chronic pain

Model Guidelines for the Use of Controlled Substances for the Treatment of Pain FSMB House of Delegates May 1998

Grant extended through 3/00 Workshops for Board Investigators (4) Developed position paper Communicated with all member boards –Position –Model Guidelines Targeted states w/out policy –Direct communication (telephone) with FSMB Legislative Staff

FSMB Pain Management Initiative: Phase 2 Improve the quality of patient care through appropriate and effective pain control –Build relationships to increase physician knowledge of current standards for appropriate pain treatment –Assist and inform the licensee population of state-specific expectations regarding physician responsibilities in treating pain